RATIONALE AND OBJECTIVES: The study was performed to evaluate the effect of magnetic resonance imaging (MRI) contrast agent (super paramagnetic iron oxide [SPIO]) on differentiation and migration of primary murine neural stem cells (NSCs) in comparison to a neural stem cell line (C17.2). Because detection of labeled cells depends on the concentration of SPIO particles per imaging voxel, the study was performed at various concentrations of SPIO particles to determine the concentration that could be used for in vivo detection of small clusters of grafted cells. MATERIALS AND METHODS: Murine primary NSCs or C17.2 cells were labeled with different concentrations of SPIO particles (0, 25, 100, and 250 microg Fe/mL) and in vitro assays were performed to assess cell differentiation. In vivo MRI was performed 7 weeks after neonatal transplantation of labeled cells to evaluate the difference in migration capability of the two cell populations. RESULTS: Both the primary NSCs and the C17.2 cells differentiated to similar number of neurons (Map2ab-positive cells). Similar patterns of engraftment of C17.2 cells were seen in transplanted mice regardless of the SPIO concentration used. In vivo MRI detection of grafted primary and C17.2 cells was only possible when cells were incubated with 100 microg/mL or higher concentration of SPIO. Extensive migration of C17.2 cells throughout the brain was observed, whereas the migration of the primary NSCs was more restricted. CONCLUSIONS: Engraftment of primary NSCs can be detected noninvasively by in vivo MRI, and the presence of SPIO particles do not affect the viability, differentiation, or engraftment pattern of the donor cells.
RATIONALE AND OBJECTIVES: The study was performed to evaluate the effect of magnetic resonance imaging (MRI) contrast agent (super paramagnetic iron oxide [SPIO]) on differentiation and migration of primary murine neural stem cells (NSCs) in comparison to a neural stem cell line (C17.2). Because detection of labeled cells depends on the concentration of SPIO particles per imaging voxel, the study was performed at various concentrations of SPIO particles to determine the concentration that could be used for in vivo detection of small clusters of grafted cells. MATERIALS AND METHODS:Murineprimary NSCs or C17.2 cells were labeled with different concentrations of SPIO particles (0, 25, 100, and 250 microg Fe/mL) and in vitro assays were performed to assess cell differentiation. In vivo MRI was performed 7 weeks after neonatal transplantation of labeled cells to evaluate the difference in migration capability of the two cell populations. RESULTS: Both the primary NSCs and the C17.2 cells differentiated to similar number of neurons (Map2ab-positive cells). Similar patterns of engraftment of C17.2 cells were seen in transplanted mice regardless of the SPIO concentration used. In vivo MRI detection of grafted primary and C17.2 cells was only possible when cells were incubated with 100 microg/mL or higher concentration of SPIO. Extensive migration of C17.2 cells throughout the brain was observed, whereas the migration of the primary NSCs was more restricted. CONCLUSIONS: Engraftment of primary NSCs can be detected noninvasively by in vivo MRI, and the presence of SPIO particles do not affect the viability, differentiation, or engraftment pattern of the donor cells.
Authors: J W Bulte; T Douglas; B Witwer; S C Zhang; E Strable; B K Lewis; H Zywicke; B Miller; P van Gelderen; B M Moskowitz; I D Duncan; J A Frank Journal: Nat Biotechnol Date: 2001-12 Impact factor: 54.908
Authors: H Okada; I F Pollack; F Lieberman; L D Lunsford; D Kondziolka; D Schiff; J Attanucci; H Edington; W Chambers; P Kalinski; D Kinzler; T Whiteside; E Elder; D Potter Journal: Hum Gene Ther Date: 2001-03-20 Impact factor: 5.695
Authors: Nona Adonai; Nora Adonai; Khoi N Nguyen; Joseph Walsh; M Iyer; Tatsushi Toyokuni; Michael E Phelps; Timothy McCarthy; Deborah W McCarthy; Sanjiv Sam Gambhir Journal: Proc Natl Acad Sci U S A Date: 2002-02-26 Impact factor: 11.205
Authors: Peter Riess; Chen Zhang; Kathryn E Saatman; Helmut L Laurer; Luca G Longhi; Ramesh Raghupathi; Philipp M Lenzlinger; Jonathan Lifshitz; John Boockvar; Edmund Neugebauer; Evan Y Snyder; Tracy K McIntosh Journal: Neurosurgery Date: 2002-10 Impact factor: 4.654
Authors: Dorota A Kedziorek; Naser Muja; Piotr Walczak; Jesus Ruiz-Cabello; Assaf A Gilad; Chunfa C Jie; Jeff W M Bulte Journal: Magn Reson Med Date: 2010-04 Impact factor: 4.668
Authors: Tanya N Weerakkody; Tapan P Patel; Cuiyong Yue; Hajime Takano; Hayley C Anderson; David F Meaney; Douglas A Coulter; John H Wolfe Journal: Mol Ther Date: 2013-07-08 Impact factor: 11.454
Authors: Manoj Kumar; Ilya M Nasrallah; Sungheon Kim; Ranjit Ittyerah; Stephen Pickup; Joel Li; Michael K Parente; John H Wolfe; Harish Poptani Journal: J Neuropathol Exp Neurol Date: 2014-01 Impact factor: 3.685
Authors: Laura E Gonzalez-Lara; Xiaoyun Xu; Klara Hofstetrova; Anna Pniak; Yuhua Chen; Catherine D McFadden; Francisco M Martinez-Santiesteban; Brian K Rutt; Arthur Brown; Paula J Foster Journal: Mol Imaging Biol Date: 2011-08 Impact factor: 3.488
Authors: Ksenia A Orlova; Whitney E Parker; Gregory G Heuer; Victoria Tsai; Jason Yoon; Marianna Baybis; Robert S Fenning; Kevin Strauss; Peter B Crino Journal: J Clin Invest Date: 2010-04-26 Impact factor: 14.808
Authors: Whitney E Parker; Ksenia A Orlova; William H Parker; Jacqueline F Birnbaum; Vera P Krymskaya; Dmitry A Goncharov; Marianna Baybis; Jelte Helfferich; Kei Okochi; Kevin A Strauss; Peter B Crino Journal: Sci Transl Med Date: 2013-04-24 Impact factor: 17.956
Authors: Victoria Tsai; Whitney E Parker; Ksenia A Orlova; Marianna Baybis; Anthony W S Chi; Benjamin D Berg; Jacqueline F Birnbaum; Jacqueline Estevez; Kei Okochi; Harvey B Sarnat; Laura Flores-Sarnat; Eleonora Aronica; Peter B Crino Journal: Cereb Cortex Date: 2012-10-18 Impact factor: 5.357